Covers a widespread view of Quality by Design (QbD) encompassing the many stages involved in the development of a new drug product.
The book provides a broad view of Quality by Design (QbD) and shows how QbD concepts and analysis facilitate the development and manufacture of high quality products. QbD is seen as a framework for building process understanding, for implementing robust and effective manufacturing processes and provides the underpinnings for a science-based regulation of the pharmaceutical industry.
Edited by the three renowned researchers in the field, Comprehensive Quality by Design for Pharmaceutical Product Development and Manufacture guides pharmaceutical engineers and scientists involved in product and process development, as well as teachers, on how to utilize QbD practices and applications effectively while complying with government regulations. The material is divided into three main sections: the first six chapters address the role of key technologies, including process modeling, process analytical technology, automated process control and statistical methodology in supporting QbD and establishing the associated design space. The second section consisting of seven chapters present a range of thoroughly developed case studies in which the tools and methodologies discussed in the first section are used to support specific drug substance and drug-product QbD related developments. The last section discussed the needs for integrated tools and reviews the status of information technology tools available for systematic data and knowledge management to support QbD and related activities.
Highlights
Comprehensive Quality by Design for Pharmaceutical Product Development and Manufacture is an ideal book for practitioners, researchers, and graduate students involved in the development, research, or studying of a new drug and its associated manufacturing process.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
GINTARAS.V. REKLAITIS, PhD, is Professor of Chemical Engineering and Industrial & Physical Pharmacy at Purdue University, member of the U.S. National Academy of Engineering, and the Deputy Director of the NSF Engineering Research Center on Structured Organic Particulate Systems.
CHRISTINE SEYMOUR, PhD, is Director in Global Regulatory Chemistry, Manufacturing & Controls at Pfizer Inc, the 2018 President of AIChE, and a Director in AIChE's Society for Biological Engineering.
SALVADOR GARCÍA-MUNOZ, PhD, is a Senior Engineering Advisor in Process Modeling and Optimization in Small Molecule Development at Eli Lilly and Company.
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Spese di spedizione:
EUR 3,73
In U.S.A.
Descrizione libro Condizione: New. Brand New. Codice articolo 0470942371
Descrizione libro Condizione: New. Codice articolo 10112884-n
Descrizione libro Condizione: New. Codice articolo 10112884-n
Descrizione libro Condizione: new. Codice articolo 562b6a418485a1d7a647cf8288257ca3
Descrizione libro HRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000. Codice articolo FW-9780470942376
Descrizione libro Hardcover. Condizione: New. Codice articolo 6666-WLY-9780470942376
Descrizione libro Gebunden. Condizione: New. GINTARAS.V. REKLAITIS, PhD, is Professor of Chemical Engineering and Industrial & Physical Pharmacy at Purdue University, member of the U.S. National Academy of Engineering, and the Deputy Director of the NSF Engineering Research Center on Structured Organi. Codice articolo 38569516
Descrizione libro Condizione: New. Buy with confidence! Book is in new, never-used condition. Codice articolo bk0470942371xvz189zvxnew
Descrizione libro Hardback. Condizione: New. New copy - Usually dispatched within 4 working days. Codice articolo B9780470942376
Descrizione libro Hardcover. Condizione: Brand New. 396 pages. 9.00x6.25x1.00 inches. In Stock. Codice articolo __0470942371